Fesilty is supplied as a lyophilized powder for reconstitution in a single-dose vial containing approximately 1g of human fibrinogen.
A new study from the University of Alberta demonstrated that the blood clotting protein called fibrinogen also regulates MMP-2, an enzyme involved in immunity and in clot formation inside blood ...
Fibryga was found to be noninferior to cryoprecipitate based on the total number of units of allogeneic blood products administered during the first 24 hours after termination of cardiopulmonary ...
KING OF PRUSSIA, Pa., July 21 CSL Behring announced todaythat it has submitted a biologics license application (BLA) to the U.S. Foodand Drug Administration (FDA) requesting approval to market its ...
The top panel, designed with BioRender.com, illustrates the process of clot formation and lysis, beginning with platelet aggregation and activation of the coagulation cascade, followed by the ...
January 28, 2009 — On January 16, the US Food and Drug Administration (FDA) granted accelerated approval to human fibrinogen concentrate (RiaSTAP, CSL Behring). This orphan drug is intended for use in ...
March 17, 2009 (San Francisco, California and Chicago, Illinois) — A small but meaningful proportion of people deemed to be at low or intermediate risk of coronary events according to Framingham ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback